Structured Summary
Abstract
A specific category of drugs that prevent sleepiness by specifically targeting sleep-mechanisms in the brain. They are used to treat DISORDERS OF EXCESSIVE SOMNOLENCE such as NARCOLEPSY. Note that this drug category does not include broadly-acting central nervous system stimulants such as AMPHETAMINES.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
Synonyms
16 entry terms
- Eugeroic Drugs
- Wake-Promoting Agents
- Wake-Promoting Drug
- Wake-Promoting Drugs
- Wake-Promoting Substances
- Agents, Wake-Promoting
- Agents, Wakefulness-Promoting
- Drug, Wake-Promoting
- Drugs, Eugeroic
- Drugs, Wake-Promoting
- Substances, Wake-Promoting
- Wake Promoting Agents
- Wake Promoting Drug
- Wake Promoting Drugs
- Wake Promoting Substances
- Wakefulness Promoting Agents
MeSH Record
Aspects Covered
24 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analysis, antagonists & inhibitors, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.
MeSH Record
History Note
2014
MeSH Record
Previous Indexing
- Sleep Disorders/drug therapy (2006-2013)
MeSH Hierarchy
Tree Number
AMA Style
References
- National Library of Medicine. Wakefulness-Promoting Agents. Medical Subject Headings (MeSH). 2026. Unique ID D064690. http://id.nlm.nih.gov/mesh/2026/D064690
- Wakefulness-Promoting Agents. In: Wikipedia. https://en.wikipedia.org/wiki/Wakefulness-promoting_agent
- Wakefulness-Promoting Agents. In: Wikidata. https://www.wikidata.org/wiki/Q50430465